MX2022002614A - Vaginal inserted estradiol pharmaceutical compositons and methods. - Google Patents
Vaginal inserted estradiol pharmaceutical compositons and methods.Info
- Publication number
- MX2022002614A MX2022002614A MX2022002614A MX2022002614A MX2022002614A MX 2022002614 A MX2022002614 A MX 2022002614A MX 2022002614 A MX2022002614 A MX 2022002614A MX 2022002614 A MX2022002614 A MX 2022002614A MX 2022002614 A MX2022002614 A MX 2022002614A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- pharmaceutical compositons
- vaginal
- estradiol pharmaceutical
- vaginal inserted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
Abstract
According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361894411P | 2013-10-22 | 2013-10-22 | |
US14/099,562 US8987237B2 (en) | 2011-11-23 | 2013-12-06 | Natural combination hormone replacement formulations and therapies |
US201461932140P | 2014-01-27 | 2014-01-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022002614A true MX2022002614A (en) | 2022-04-11 |
Family
ID=55697531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022002614A MX2022002614A (en) | 2013-10-22 | 2016-04-20 | Vaginal inserted estradiol pharmaceutical compositons and methods. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3060179A4 (en) |
JP (1) | JP6680672B2 (en) |
KR (2) | KR102335160B1 (en) |
AU (3) | AU2014349132A1 (en) |
BR (1) | BR112016009008B8 (en) |
IL (1) | IL245139B (en) |
MX (1) | MX2022002614A (en) |
RU (1) | RU2713888C2 (en) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2739558B1 (en) * | 1995-10-05 | 1997-11-28 | Innothera Lab Sa | UNITAL GALENIC FORM FOR LOCAL HORMONOTHERAPY OF VAGINAL DROUGHT |
FR2759292B1 (en) * | 1997-02-10 | 2000-08-11 | Cird Galderma | USE OF RETINOIDS AS PIGMENTATION INDUCING AGENTS |
WO1999022680A1 (en) * | 1997-11-03 | 1999-05-14 | Deschutes Medical Products, Inc. | Pessary with medicated cartridge |
JP2002510336A (en) * | 1998-04-11 | 2002-04-02 | エレカッパ・ユウロテラピッチ・ソシエタ・ペル・アチオニ | Pharmaceutical preparations containing water-soluble ketoprofen salts and methods of using the same |
WO2003039524A1 (en) * | 2001-11-09 | 2003-05-15 | Pharmacia Ab | Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder |
WO2004054576A1 (en) * | 2002-12-18 | 2004-07-01 | Ferrer Internacional, S.A. | Pharmaceutical compositions of sertaconazole for vaginal use |
US20060040904A1 (en) * | 2004-08-17 | 2006-02-23 | Ahmed Salah U | Vaginal cream compositions, kits thereof and methods of using thereof |
EP1912623A2 (en) * | 2005-08-12 | 2008-04-23 | Drugtech Corporation | Estrogen compositions and therapeutic methods of use thereof |
EP1872775A1 (en) * | 2006-06-29 | 2008-01-02 | Polichem S.A. | Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
HUE055562T2 (en) * | 2011-11-23 | 2021-11-29 | Therapeuticsmd Inc | Natural combination hormone replacement formulations and therapies |
JP6342334B2 (en) * | 2012-01-26 | 2018-06-13 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | Transdermal hormone replacement therapy |
WO2013130535A1 (en) * | 2012-02-27 | 2013-09-06 | Newgen Biopharma Corporation | Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same |
-
2014
- 2014-10-22 RU RU2016118396A patent/RU2713888C2/en active
- 2014-10-22 EP EP14862905.8A patent/EP3060179A4/en not_active Withdrawn
- 2014-10-22 JP JP2016516086A patent/JP6680672B2/en active Active
- 2014-10-22 KR KR1020167010901A patent/KR102335160B1/en active IP Right Grant
- 2014-10-22 BR BR112016009008A patent/BR112016009008B8/en active IP Right Grant
- 2014-10-22 AU AU2014349132A patent/AU2014349132A1/en not_active Abandoned
- 2014-10-22 KR KR1020217039281A patent/KR102488424B1/en active IP Right Grant
-
2016
- 2016-04-14 IL IL245139A patent/IL245139B/en active IP Right Grant
- 2016-04-20 MX MX2022002614A patent/MX2022002614A/en unknown
-
2019
- 2019-06-28 AU AU2019204658A patent/AU2019204658B2/en active Active
-
2021
- 2021-08-20 AU AU2021218231A patent/AU2021218231A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
RU2713888C2 (en) | 2020-02-10 |
AU2019204658A1 (en) | 2019-07-18 |
AU2014349132A1 (en) | 2016-04-14 |
IL245139B (en) | 2020-08-31 |
IL245139A0 (en) | 2016-06-30 |
KR20160062097A (en) | 2016-06-01 |
BR112016009008A2 (en) | 2017-08-01 |
KR102335160B1 (en) | 2021-12-03 |
KR20210148435A (en) | 2021-12-07 |
JP2016534025A (en) | 2016-11-04 |
AU2019204658B2 (en) | 2021-05-20 |
AU2021218231A1 (en) | 2021-09-09 |
BR112016009008B1 (en) | 2022-09-06 |
EP3060179A4 (en) | 2017-05-17 |
AU2014349132A8 (en) | 2016-07-14 |
RU2016118396A3 (en) | 2018-07-17 |
RU2016118396A (en) | 2017-11-28 |
KR102488424B1 (en) | 2023-01-12 |
BR112016009008B8 (en) | 2023-01-31 |
JP6680672B2 (en) | 2020-04-15 |
EP3060179A1 (en) | 2016-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014015899A (en) | Soluble estradiol capsule for vaginal insertion. | |
PH12016500024A1 (en) | Bromodomain inhibitor | |
PH12015502261A1 (en) | Macrocyclic deaza-purinones for the treatment of viral infections | |
PH12015501648A1 (en) | 2-aminopyrimidine derivatives for the treatment of viral infections | |
TN2013000310A1 (en) | Effervescent composition in solid form for use in vaginal applications for the treatment of vaginal infections | |
IN2015MN00478A (en) | ||
MX2015009106A (en) | Solid solution compositions and use in severe pain. | |
TN2012000161A1 (en) | Spiro-oxindole mdm2 antagonists | |
MX2016008448A (en) | Var2csa-drug conjugates. | |
IN2013MU03583A (en) | ||
MX2015012833A (en) | Ceftolozane antibiotic compositions. | |
MX2016005092A (en) | Vaginal inserted estradiol pharmaceutical compositons and methods. | |
TR201910866T4 (en) | Combined preparations for cancer treatment. | |
MX2016008150A (en) | Berberine formulations and uses thereof. | |
AU2016356504A8 (en) | 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential | |
PH12015502564B1 (en) | Pyridone derivatives for the treatment of viral infections and further diseases | |
MX2015016603A (en) | Corticosteroid compositions. | |
MX370990B (en) | Esters of oligo-hydroxycarboxylic acids and use thereof. | |
EA201492238A1 (en) | COMPOSITION MIZOPROSTOL | |
MX2022002614A (en) | Vaginal inserted estradiol pharmaceutical compositons and methods. | |
MX2016004961A (en) | Methods and compositions for treatment of s. equi infection. | |
EP3386514A4 (en) | Vaginal inserted estradiol pharmaceutical compositions and methods | |
SG10201810362SA (en) | Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition | |
UA92840U (en) | Dehydration-dehreasignation solution for plastination of anatomical preparations | |
MY180947A (en) | Ceftolozane antibiotic compositions |